Janus Henderson Group plc 13D and 13G filings for AN2 Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-12 2:05 pm Purchase |
2023-12-31 | 13G | AN2 Therapeutics, Inc. ANTX |
JANUS HENDERSON GROUP PLC JHG |
1,279,975 4.300% |
279,899 (+27.99%) |
Filing |
| 2023-07-05 4:55 pm Purchase |
2023-06-26 | 13G | AN2 Therapeutics, Inc. ANTX |
JANUS HENDERSON GROUP PLC JHG |
1,000,076 5.100% |
1,000,076 (New Position) |
Filing |